• FirefoxUpgrade to the new Firefox »
  •  Dow Up1.31% Nasdaq Up0.98%

    Hyperion Therapeutics, Inc. (HPTX)

    -NasdaqGS
    26.03 Up 0.98(3.91%) Jan 29, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 42,204   -   -  
    Cost of Revenue6,740   -   -  
    Gross Profit 35,464   -   -  
    Operating Expenses
    Research Development9,984  17,046  17,236  
    Selling General and Administrative35,839  11,487  8,923  
    Non Recurring -   -   -  
    Others3,058   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (13,417) (28,533) (26,159)
    Income from Continuing Operations
    Total Other Income/Expenses Net31,632  (27)(703)
    Earnings Before Interest And Taxes18,215  (28,560)(26,862)
    Interest Expense1,539  3,703  2,554  
    Income Before Tax16,676  (32,263)(29,416)
    Income Tax Expense49   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops16,627  (32,263)(29,416)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 16,627   (32,263) (29,416)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 16,627   (32,263) (29,416)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.